Liliang Chen Selected Research

AAP 10

1/2017

Improved Anticancer Photothermal Therapy Using the Bystander Effect Enhanced by Antiarrhythmic Peptide Conjugated Dopamine-Modified Reduced Graphene Oxide Nanocomposite.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Liliang Chen Research Topics

Disease

2	Neoplasms (Cancer) 01/2017 - 03/2015
2	Breast Neoplasms (Breast Cancer) 01/2017 - 03/2015
1	Stroke (Strokes) 05/2021
1	Acute Monocytic Leukemia (Acute Monoblastic Leukemia) 05/2017

Drug/Important Bio-Agent (IBA)

3	graphene oxideIBA 05/2017 - 03/2015
2	Proteins (Proteins, Gene)FDA Link 01/2017 - 03/2015
1	Dopamine (Intropin)FDA LinkGeneric 01/2017
1	Connexin 43 (Connexin43)IBA 01/2017
1	Peptides (Polypeptides)IBA 01/2017
1	AAP 10IBA 01/2017
1	polydopamineIBA 01/2017
1	Therapeutic UsesIBA 03/2015
1	APTIBA 03/2015
1	Glycoproteins (Glycoprotein)IBA 03/2015
1	GoldIBA 03/2015
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 03/2015
1	MucinsIBA 03/2015

Therapy/Procedure

2	Photothermal Therapy 01/2017 - 03/2015
2	Therapeutics 01/2017 - 03/2015
1	Activities of Daily Living (ADL) 05/2021